Ominous blue coronavirus cells intertwined with DNA and white blood cells on dark

Italian Researchers Identify Common Susceptibility Genes in COVID-19 Patients

The researchers looked to identify genetic differences with clinical outcomes. Using that study form, for each patient, the team identified an average of three disease-causing mutations involved in COVID-19 susceptibility.

Abbott Launching ID NOW COVID-19 Tests, Offering Positive Results in Five Minutes

Company expects to deliver 50,000 tests per day of the rapid, instrument-based, isothermal system designed for qualitative detection of infectious diseases.
Doctor holding Coronavirus vaccine. COVID 19 concept

Some COVID-19 Vaccines More Effective Against New Strains Than Others

Recent results suggest that the Pfizer/BioNTech COVID-19 vaccine has good efficacy against the new UK and South African variants. But the AstraZeneca/Oxford University vaccine appears less effective against the South African variant, a trend emerging for several approved or near-approved vaccines.
Potential coronavirus drugs, illustration

Four Promising Antiviral Drug Candidates Identified to Fight COVID-19

The researchers, based at University of South Florida Health and the University of Arizona College of Pharmacy, worked together to screen 55 possible antiviral compounds to assess their ability to treat SARS-CoV-2.
Electron microscopy virus visualization

Gene Expression Studies Reveal New COVID-19 Inflammatory Response Pathway

The team, led by Dan Jacobson of the Department of Energy's Oak Ridge National Laboratory, found that genes in the bradykinin system were excessively activated in the lung fluid cells of COVID-19 patients.
Sick woman with Long COVID lying in bed

Gene Expression Changes Could Be Behind Long-Haul COVID-19 Symptoms

Exposure to the SARS-CoV-2 spike protein alone was enough to change baseline gene expression in airway cells in early stage research, suggesting a possible cause for long COVID symptoms.
Senior male smoking cigarette on black background

Smokers, COPD Patients’ Increased Levels of ACE2 Receptors Make Them More Vulnerable to SARS-CoV-2...

SARS-CoV-2 uses the ACE-2 receptor as a cellular entry receptor, the authors wrote. While the virus can infect people of any age, most of the severe cases, to date, have been in individuals over the age of 55 years and with significant comorbidities, such as COPD.

Leprosy Drug Shows Potential as At-Home Treatment for COVID-19

Clofazimine, which was discovered in 1954, is FDA approved and on the World Health Organization’s List of Essential Medicines. The drug’s utility for COVID-19 was initially identified by screening more than 12,000 drugs from the ReFRAME drug library.

Mining the Microbiome: Microbiome startups are proliferating, exploring new markets, and colonizing diverse therapeutic...

It would be hard to find an area of health where the microbiome has not been implicated as a major player. The microbiome is...
doctor hold coronavirus vaccine in hospital laboratory

BioNTech/Pfizer Vaccination Analysis Confirms High Overall Efficacy

Results from an analysis of COVID-19 vaccination data from Israel show over 90% protection from SARS-CoV-2 infection with the BioNTech/Pfizer vaccine. However, there was a decrease in efficacy in much older individuals and those with serious chronic conditions like diabetes.